08.05.2026
Prevent & Delay
$2,225,812.00
36 months
Restoring Immune Tolerance in Type 1 Diabetes Using Antigen-Specific Regulatory B Cells
To support preclinical studies to develop a new engineered cell therapy for type 1 diabetes.